“…MU is a potential complication following RYGB, which typically occurs at or near the gastrojejunal anastomosis, with a reported mean incidence rate of 4.6% [ 8 , 9 , 10 ]. While the pathophysiology of MU remains unclear, there are several potential risk factors that have been identified, including smoking, diabetes, use of nonsteroidal anti-inflammatory drugs (NSAID), Helicobacter pylori infection, and alcohol consumption, among others [ 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 ]. Symptoms of MU can vary, with some patients being asymptomatic while others present with nausea/vomiting, abdominal pain, or gastrointestinal (GI) bleeding, potentially explaining the variability in the reported incidence rates [ 8 , 18 ].…”